Seminars in Oncology Nursing
Volume 22 , Pages 1-4 , February 2006

Targeted Therapies: A Nursing Perspective

  • Polly Kay

      Affiliations

    • Corresponding Author InformationAddress correspondence to Polly Kay, RN, UCLA Clinical Research Unit, 10945 Le Conte Ave, PVUB 3360, Los Angeles, CA 90095

References 

  1. Gschwind A , Fischer OM , Ullrich A . The discovery of receptor tyrosine kinases (Targets for cancer therapy) . Nat Rev . 2004;4:361–370
  2. Deininger M , Buchdunger E , Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukemia . Blood . 2005;105:2640–2653
  3. Collins TS , Hurwitz HI . Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer . Semin Oncol . 2005;32:61–68
  4. Herbst RS , Shin DM . Monoclonal antibodies to target epidermal growth factor receptor-positive tumors (A new paradigm for cancer therapy) . Cancer . 2002;94:1593–1611
  5. In: Physicians Desk Reference . 59th ed.. Montvale, NJ: Thomson PDR; 2005;
  6. Rastetter W , Molina A , White CA . Rituximab (Expanding role in therapy for lymphomas and autoimmune diseases) . Annu Rev Med . 2004;55:477–503
  7. Rituxan [package insert]. South San Francisco, CA. Genentech, Inc, and San Diego, CA: Biogen Idec Inc; 2005.
  8. Gleevec tablets [package insert] . East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2005;
  9. Emens LA , Davidson NE . Trastuzumab in breast cancer . Oncology . 2004;18:1117–1128
  10. Herceptin [package insert] . San Francisco, CA: Genentech, Inc; 2005;
  11. ERBITUX [package insert]. New York, NY. ImClone Systems Incorporated, and Princeton, NJ: Bristol-Myers Squibb Company; 2004.
  12. Salomon DS , Brandt R , Ciardiello F , et al.   Epidermal growth factor-related peptides and their receptors in human malignancies . Crit Rev Oncol Hematol . 1995;19:183–232
  13. Tarceva tablets [package insert]. South San Francisco, CA. Genentech, Inc, and Melville, NY: OSI Pharmaceuticals Inc; 2004.
  14. Iressa tablets [package insert] . Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2004;
  15. Avastin [package insert] . South San Francisco, CA: Genentech, Inc; 2005;
  16. Jain RK . Recognition of tumor blood vessel normalization as a new angiogenic concept [reply to letter] . Nat Med . 2004;10:329–330
  17. Orlowski RZ . Bortezomib and its role in the management of patients with multiple myeloma . Expert Rev Anticancer Ther . 2004;4:171–179
  18. Velcade [package insert] . Cambridge, MA: Millennium Pharmaceuticals, Inc; 2004;
  19. Govindan R . Cetuximab in advanced non–small cell lung cancer . Clin Cancer Res . 2004;10(suppl 1):4241s–4244s

 Supported in part by a grant from Bristol-Myers Squibb Company.

PII: S0749-2081(06)00032-5

doi: 10.1016/j.soncn.2006.01.009

Seminars in Oncology Nursing
Volume 22 , Pages 1-4 , February 2006

Article Tools